Insights

Sustainability edge Synterex is a woman-owned and disability-owned DBE that has won sustainability awards and is recognized for its environmental and policy-driven initiatives. This positions the company as a partner for biologics and regulatory programs that prioritize ESG credentials and responsible innovation.

AI driven writing The flagship AgileWriter.ai platform delivers accelerated clinical documentation with accessibility compliance (ATAG) and language generation that reduces manual doc creation time by up to 50%. This creates a compelling value proposition for CROs and biopharma sponsors seeking faster time-to-document delivery.

Regulatory agility Synterex combines clinical writing with agile methodology and automated AI-enabled workflows, appealing to clients needing compliant, rapid development support across clinical development, regulatory submissions, and health authority interactions.

Growth recognition Repeated inclusion in Fast 50 lists and awards from SBA and sustainability programs signal strong growth trajectory and credibility, making Synterex a lower-risk partner for tiered outsourcing arrangements and long-term engagements.

SMB to mid-market fit With 11-50 employees and revenue in the multi-million range, Synterex targets firms that require agile, scalable regulatory and writing services without the overhead of large CROs, presenting opportunities for strategic partnerships, multi-year scopes, and co-developed solutions.

Similar companies to Synterex

Synterex Tech Stack

Synterex uses 8 technology products and services including Microsoft Advertising, Usercentrics, WordPress, and more. Explore Synterex's tech stack below.

Media & News

Synterex's Email Address Formats

Synterex uses at least 2 email formats:
Synterex Email FormatsExamplePercentage
FLast@synterex.comJDoe@synterex.com
94%
Last@synterex.comDoe@synterex.com
6%

Frequently Asked Questions

What is Synterex's official website and social media links?

Minus sign iconPlus sign icon
Synterex's official website is synterex.com and has social profiles on LinkedIn.

How much revenue does Synterex generate?

Minus sign iconPlus sign icon
As of August 2026, Synterex's annual revenue is estimated to be $10M - $25M.

What is Synterex's SIC code and NAICS code?

Minus sign iconPlus sign icon
Synterex's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Synterex have currently?

Minus sign iconPlus sign icon
As of August 2026, Synterex has approximately 33 employees across 3 continents, including North America, Europe and Africa. Key team members include Human Resources Manager: N. P., Senior Medical Writer: D. H. and Medical Writer: T. F. Explore Synterex's employee directory with LeadIQ.

What industry does Synterex belong to?

Minus sign iconPlus sign icon
Synterex operates in the Biotechnology Research industry.

What technology does Synterex use?

Minus sign iconPlus sign icon
Synterex's tech stack includes Microsoft Advertising, Usercentrics, WordPress, SAP, Microsoft Azure, BambooHR, Microsoft Teams and Wrike.

What is Synterex's email format?

Minus sign iconPlus sign icon
Synterex's email format typically follows the pattern of FLast@synterex.com. Find more Synterex email formats with LeadIQ.

When was Synterex founded?

Minus sign iconPlus sign icon
Synterex was founded in 2008.
Synterex logo

Synterex

Biotechnology ResearchMassachusetts, United States11-50 Employees

Synterex is a small to midsize biotechnology research firm based in Dedham, Massachusetts, offering clinical and regulatory consulting services. It is woman-owned (WBENC) and disability-owned (DOBE), and it emphasizes agile methods, automation, and AI-driven approaches to clinical writing and development. The company helps clients bring new therapies to patients more quickly by providing writing and development solutions that streamline documentation and regulatory workflows, including a platform that can trim up to 50% of the time typically spent on manual document creation and management. In October 2023, Synterex announced the launch of AgileWriter, an AI-enabled authoring tool for clinical documentation with a strong emphasis on accessibility and compliance with authoring guidelines. The platform is designed to support diverse source formats and improve readability while reducing manual effort. 

Beyond writing solutions, Synterex provides IT services aimed at improving operational performance through project management, client communication, and technical execution, including environment migrations, health checks, system deployments and support. The firm serves clients within biotechnology research and related clinical development who require regulatory and documentation expertise to advance therapies. Based in Dedham, Massachusetts, the company is recognized as a fast-growing private organization and has earned honors such as the Sustainability Initiative award in 2023. The overall focus remains on delivering efficient, compliant documentation and development outcomes for the biotech and regulatory landscape.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Synterex's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.